Company · CIK 0001750149 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Inhibikase Therapeutics, Inc. · IKT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 MForm 4 → | Jul 31, 4:05 pm EDT | Dennis N BermanDirector | 21,854 | $1.26 | $27,536 | 21,854 | — | |
| Jul 29, 2026 JForm 4 → | Jul 31, 4:32 pm EDT | RA CAPITAL MANAGEMENT, L.P. +310% Owner | 18,030,000 | — | — | 6,970,000 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 MForm 4 → | Jul 31, 4:05 pm EDT | Dennis N BermanDirector | 21,854 | — | — | 0 | — | |
| Jul 29, 2026 JForm 4 → | Jul 31, 4:32 pm EDT | RA CAPITAL MANAGEMENT, L.P. +310% Owner | 18,030,000 | — | — | 18,030,000 | — |